CRBU eyeing 2,5$CRBU eyeing 2,5 dollar with a nice RSI divergence after being beat down. Has to first go trough green resistance line channel to make it to 2,5$, GL all
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.6518 USD
−149.10 M USD
9.99 M USD
80.81 M
About Caribou Biosciences, Inc.
Sector
Industry
CEO
Rachel E. Haurwitz
Website
Headquarters
Berkeley
Founded
2011
FIGI
BBG008G28LJ5
Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. The company was founded by Jennifer A. Doudna, Rachel E. Haurwitz, Martin Jinek and James Berger on October 28, 2011 and is headquartered in Berkeley, CA.
CRBU Caribou Biosciences Options Ahead of EarningsAnalyzing the options chain and the chart patterns of CRBU Caribou Biosciences prior to the earnings report this week,
I would consider purchasing the 5usd strike price in the money Calls with
an expiration date of 2023-9-15,
for a premium of approximately $0.85.
If these options prove to be profita
CRBUDon't you have enough capital?
No problem. There are always new opportunities at stock market.
This a long bullish trade.
The areas close to the circle are pending orders that need to be filled.
Charts don't lie
CRBU | InformativeNASDAQ:CRBU
If the price of CRBU breaks above the bullish line of $7.49, it may indicate a bullish signal, suggesting potential upward price movement. In this scenario, the target price could be set at $8.65.
Conversely, if the price of CRBU breaks below the bearish line of $6.86, it may suggest
CRBU looking like a good tradeWe have bottomed out here potentially and appear to be under accumulation on the higher time frames. The Bollinger Bands are compressing quite nicely and we could have a nice little squeeze up to the the 200 ma or higher in my opinion. Not financial advice, DYOR.
“Caribou is a leader in the CRISP
$CRBU IPO Low Cheat Setup$CRBU low cheat IPO base. Forming just below the 50 MA which is typical of low cheats and thus carry added risk.
Looks orderly with okay potential.
$CRBU is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $18,13;
stop-loss — $1
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of CRBU is 0.7740 USD — it has decreased by −11.30% in the past 24 hours. Watch Caribou Biosciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Caribou Biosciences, Inc. stocks are traded under the ticker CRBU.
CRBU stock has risen by 7.50% compared to the previous week, the month change is a −18.98% fall, over the last year Caribou Biosciences, Inc. has showed a −79.63% decrease.
We've gathered analysts' opinions on Caribou Biosciences, Inc. future price: according to them, CRBU price has a max estimate of 32.00 USD and a min estimate of 1.00 USD. Watch CRBU chart and read a more detailed Caribou Biosciences, Inc. stock forecast: see what analysts think of Caribou Biosciences, Inc. and suggest that you do with its stocks.
CRBU reached its all-time high on Sep 7, 2021 with the price of 32.6450 USD, and its all-time low was 0.6600 USD and was reached on Apr 7, 2025. View more price dynamics on CRBU chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CRBU stock is 16.61% volatile and has beta coefficient of 2.25. Track Caribou Biosciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Caribou Biosciences, Inc. there?
Today Caribou Biosciences, Inc. has the market capitalization of 71.99 M, it has decreased by −15.93% over the last week.
Yes, you can track Caribou Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
Caribou Biosciences, Inc. is going to release the next earnings report on May 13, 2025. Keep track of upcoming events with our Earnings Calendar.
CRBU earnings for the last quarter are −0.39 USD per share, whereas the estimation was −0.42 USD resulting in a 6.58% surprise. The estimated earnings for the next quarter are −0.44 USD per share. See more details about Caribou Biosciences, Inc. earnings.
Caribou Biosciences, Inc. revenue for the last quarter amounts to 2.08 M USD, despite the estimated figure of 2.11 M USD. In the next quarter, revenue is expected to reach 1.75 M USD.
CRBU net income for the last quarter is −35.49 M USD, while the quarter before that showed −34.68 M USD of net income which accounts for −2.32% change. Track more Caribou Biosciences, Inc. financial stats to get the full picture.
No, CRBU doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 26, 2025, the company has 147 employees. See our rating of the largest employees — is Caribou Biosciences, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Caribou Biosciences, Inc. EBITDA is −162.69 M USD, and current EBITDA margin is −1.63 K%. See more stats in Caribou Biosciences, Inc. financial statements.
Like other stocks, CRBU shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Caribou Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Caribou Biosciences, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Caribou Biosciences, Inc. stock shows the sell signal. See more of Caribou Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.